Spots Global Cancer Trial Database for palbociclib 75mg
Every month we try and update this database with for palbociclib 75mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer | NCT03709082 | HER2-positive B... Breast Cancer M... | Palbociclib 75m... Letrozole 2.5mg T-DM1 Palbociclib 100... Palbociclib 125... Palbociclib | 18 Years - | University of Kansas Medical Center |